Your browser doesn't support javascript.
loading
Study Protocol PROMETHEUS: Prospective Multicenter Study to Evaluate the Correlation Between Safety Margin and Local Recurrence After Thermal Ablation Using Image Co-registration in Patients with Hepatocellular Carcinoma.
Oosterveer, Timo T M; van Erp, Gonnie C M; Hendriks, Pim; Broersen, Alexander; Overduin, Christiaan G; van Rijswijk, Carla S P; van Erkel, Arian R; van der Meer, Rutger W; Tushuizen, Maarten E; Moelker, Adriaan; Meijerink, Martijn R; van Delden, Otto M; de Jong, Koert P; van der Leij, Christiaan; Smits, Maarten L J; Urlings, Thijs A J; Braak, Jeffrey P B M; Meershoek-Klein Kranenbarg, Elma; van Duijn-de Vreugd, Bianca; Zeijdner, Evelijn; Goeman, Jelle J; Fütterer, Jurgen J; Coenraad, Minneke J; Dijkstra, Jouke; Burgmans, Mark C.
Afiliación
  • Oosterveer TTM; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands. t.t.m.oosterveer@lumc.nl.
  • van Erp GCM; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands.
  • Hendriks P; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands.
  • Broersen A; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands.
  • Overduin CG; Division of Image Processing, Leiden University Medical Center, Leiden, The Netherlands.
  • van Rijswijk CSP; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Erkel AR; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands.
  • van der Meer RW; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands.
  • Tushuizen ME; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands.
  • Moelker A; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
  • Meijerink MR; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van Delden OM; Department of Radiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • de Jong KP; Department of Radiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • van der Leij C; Department of Hepatobiliary and Pancreatic Surgery, University Medical Center Groningen, Groningen, The Netherlands.
  • Smits MLJ; Department of Radiology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Urlings TAJ; Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Braak JPBM; Department of Radiology, Haaglanden Medical Center, Hague, The Netherlands.
  • Meershoek-Klein Kranenbarg E; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • van Duijn-de Vreugd B; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Zeijdner E; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands.
  • Goeman JJ; Dutch Oncology Research Platform, Utrecht, The Netherlands.
  • Fütterer JJ; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
  • Coenraad MJ; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Dijkstra J; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
  • Burgmans MC; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands.
Cardiovasc Intervent Radiol ; 45(5): 606-612, 2022 May.
Article en En | MEDLINE | ID: mdl-35233662
ABSTRACT

PURPOSE:

The primary objective is to determine the minimal ablation margin required to achieve a local recurrence rate of < 10% in patients with hepatocellular carcinoma undergoing thermal ablation. Secondary objectives are to analyze the correlation between ablation margins and local recurrence and to assess efficacy. MATERIALS AND

METHODS:

This study is a prospective, multicenter, non-experimental, non-comparative, open-label study. Patients > 18 years with Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma (or B with a maximum of two lesions < 5 cm each) are eligible. Patients will undergo dual-phase contrast-enhanced computed tomography directly before and after ablation. Ablation margins will be quantitatively assessed using co-registration software, blinding assessors (i.e. two experienced radiologists) for outcome. Presence and location of recurrence are evaluated independently on follow-up scans by two other experienced radiologists, blinded for the quantitative margin analysis. A sample size of 189 tumors (~ 145 patients) is required to show with 80% power that the risk of local recurrence is confidently below 10%. A two-sided binomial z-test will be used to test the null hypothesis that the local recurrence rate is ≥ 10% for patients with a minimal ablation margin ≥ 2 mm. Logistic regression will be used to find the relationship between minimal ablation margins and local recurrence. Kaplan-Meier estimates are used to assess local and overall recurrence, disease-free and overall survival.

DISCUSSION:

It is expected that this study will result in a clear understanding of the correlation between ablation margins and local recurrence. Using co-registration software in future patients undergoing ablation for hepatocellular carcinoma may improve intraprocedural evaluation of technical success. Trial registration The Netherlands Trial Register (NL9713), https//www.trialregister.nl/trial/9713 .
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ablación por Catéter / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cardiovasc Intervent Radiol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ablación por Catéter / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cardiovasc Intervent Radiol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos